The Codeine Conundrum: Mapping the Safety Story

July 7, 2017

In April 2017, the FDA strengthened warnings and contraindications around codeine- and tramadol-containing products as a result of a review of adverse events from 1969 to May 2015.  This podcast reviews details of these warnings and contraindications.

Presenters:
Rabiah Dys, PharmD
Division Vice President
Clinical Program Development, CPS

Valerie Sheehan, PharmD
Director, Clinical Program Development, CPS

Watch Now: